These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7711008)

  • 41. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes.
    Ali AA; Velasquez MT; Hansen CT; Mohamed AI; Bhathena SJ
    J Nutr Biochem; 2004 Oct; 15(10):583-90. PubMed ID: 15542349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
    Malminiemi K; Lahtela JT; Huupponen R
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):156-63. PubMed ID: 7599914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin resistance: the link between impaired glucose tolerance, body mass index and plasma lipids.
    Mincu I; Ionescu-Tîrgovişte C; Moldovan A; Mirodon Z; Georgescu M; Ionescu L; Tinu AM
    Rom J Intern Med; 1993; 31(4):237-43. PubMed ID: 8148775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Profile of dyslipidemia in Psammomys obesus, an animal model of the metabolic syndrome.
    Walder K; Oakes N; Fahey RP; Cooney G; Zimmet PZ; Collier GR
    Endocr Regul; 2002 Mar; 36(1):1-8. PubMed ID: 11971745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of retinal vascular abnormalities in lean and obese spontaneously hypertensive rats.
    Huang SS; Khosrof SA; Koletsky RJ; Benetz BA; Ernsberger P
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S129-31. PubMed ID: 9072324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters.
    Luo S; Liang Y; Cincotta AH
    Neuroendocrinology; 1999 Mar; 69(3):160-6. PubMed ID: 10087448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bromocriptine redirects metabolism and prevents seasonal onset of obese hyperinsulinemic state in Syrian hamsters.
    Cincotta AH; MacEachern TA; Meier AH
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E285-93. PubMed ID: 8447396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic features in disease-resistant as well as in spontaneously hypertensive rats and newly established obese Wistar Ottawa Karlsburg inbred rats.
    van den Brandt J; Kovács P; Klöting I
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1618-22. PubMed ID: 11126214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma lipids and other factors in the LA/N corpulent rat in the presence of chronic exercise and food restriction.
    Russell JC; Amy RM
    Can J Physiol Pharmacol; 1986 Jun; 64(6):750-6. PubMed ID: 3756628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats.
    Ezrokhi M; Luo S; Trubitsyna Y; Cincotta AH
    Diabetol Metab Syndr; 2014; 6():104. PubMed ID: 25937836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathophysiological differences between obese and non-obese spontaneously hypertensive rats.
    Wexler BC; Iams SG; McMurtry JP
    Br J Exp Pathol; 1980 Apr; 61(2):195-207. PubMed ID: 7426376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in saline and water intakes in bromocriptine-treated genetically hypertensive and normotensive rats.
    Tan BK; Hutchinson JS
    Clin Exp Pharmacol Physiol; 1990 Feb; 17(2):129-33. PubMed ID: 2328543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reductions of body fat stores and total plasma cholesterol and triglyceride concentrations in several species by bromocriptine treatment.
    Cincotta AH; Meier AH
    Life Sci; 1989; 45(23):2247-54. PubMed ID: 2601578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wistar fatty rat is obese and spontaneously hypertensive.
    Yamakawa T; Tanaka S; Tamura K; Isoda F; Ukawa K; Yamakura Y; Takanashi Y; Kiuchi Y; Umemura S; Ishiiu M
    Hypertension; 1995 Jan; 25(1):146-50. PubMed ID: 7843747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bromocriptine and insulin sensitivity in lean and obese subjects.
    Bahler L; Verberne HJ; Brakema E; Tepaske R; Booij J; Hoekstra JB; Holleman F
    Endocr Connect; 2016 Nov; 5(6):44-52. PubMed ID: 27758845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for a noradrenergic mechanism causing hypertension and abnormal glucose metabolism in rats with relative deficiency of gamma-melanocyte-stimulating hormone.
    Ni XP; van Dijk C; Pearce D; Humphreys MH
    Exp Physiol; 2009 Aug; 94(8):867-76. PubMed ID: 19429645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smokeless nicotine administration is associated with hypertension but not with a deterioration in glucose tolerance in rats.
    Swislocki AL; Tsuzuki A; Tait M; Khuu D; Fann K
    Metabolism; 1997 Sep; 46(9):1008-12. PubMed ID: 9284888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of bromocryptine on hormone and blood pressure levels in the spontaneously hypertensive rat.
    McMurtry JP; Kazama N; Wexler BC
    Proc Soc Exp Biol Med; 1979 Jun; 161(2):186-8. PubMed ID: 450925
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of weight reduction on abnormal serum transaminase values, hyperlipidemia and oral glucose intolerance in male obese subjects (author's transl)].
    Yoshitsugu M; Iwase T; Sassa R
    Nihon Shokakibyo Gakkai Zasshi; 1980 Jun; 77(6):927-34. PubMed ID: 7411984
    [No Abstract]   [Full Text] [Related]  

  • 60. Jogging reduces obesity and hypertension in obese/SHR.
    Wexler BC
    Proc Soc Exp Biol Med; 1983 Sep; 173(4):541-6. PubMed ID: 6310622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.